Table 4

Self-reported non-adherence to individual secondary prevention medicines before and after the medicines optimisation clinic

Secondary prevention medicineNon-adherence rate prior to clinicNon-adherence rate 3–6 months post-clinicRelative reduction in non-adherenceP value
ACE inhibitor /ARB27/178 (15.2%)10/130 (7.7%)49.3%0.046
Beta blocker23/169 (13.6%)5/119 (4.2%)69.1%0.008
Statin39/181 (21.5%)8/127 (6.3%)70.8%<0.001
Clopidogrel/prasugrel/ticagrelor32/173 (18.5%)7/126 (5.6%)69.7%0.001
Aspirin24/176 (13.6%)10/128 (7.8%)42.6%0.112
  • ARB, angiotensin receptor blocker.ACE, Angiotensin-Converting Enzyme.